Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,633–1,640 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Eloxx Pharmaceuticals Inc. ELX-02 Cystinosis Phase 2 Intravenous Genetic Disorder
Eloxx Pharmaceuticals Inc. ELX-02 Alport syndrome Phase 2 Intravenous Genetic Disorder
Emergent BioSolutions Inc. COVID-EIG COVID-19 Phase 2 Trial Planned Intramuscular COVID-19
Enanta Pharmaceuticals Inc. zelicapavir (EDP-938) (RSVP) Respiratory Syncytial Virus (community-acquired) Phase 2b Ongoing oral Respiratory
Enanta Pharmaceuticals Inc. EDP-235 - (SPRINT) COVID-19 Phase 2 Data Released oral COVID-19
Enanta Pharmaceuticals Inc. Zelicapavir (EDP-938) - (RSVHR) Respiratory Syncytial Virus Infections (RSV) Phase 2b Data Released Oral Respiratory
Enanta Pharmaceuticals Inc. EDP-305 INTREPID Primary biliary cholangitis (PBC) Phase 2 Trial Discontinued Oral Gastroenterology
Enanta Pharmaceuticals Inc. EDP-305 - (ARGON-2) Non-alcoholic steatohepatitis (NASH) Phase 2b Trial Discontinued Oral Gastroenterology